All Sauce from Weekly Sauce:

Two new studies on pain relief suggest there is a safer alternative to addictive opioid painkillers after knee and shoulder surgery. The findings dovetail with changes to voluntary federal guidelines for prescribing opioid painkillers proposed by the U.S. Centers for Disease Control and Prevention last week. The proposal urges doctors to prescribe non-opioid therapies whenever…  read on >  read on >

MONDAY, Feb. 14, 2022 (HealthDay News) – Comedian Bob Saget died after a severe blow to his head fractured his skull in several spots and caused bleeding across both sides of his brain, an autopsy report shows. “It is most probable that the decedent suffered an unwitnessed fall backwards and struck the posterior aspect of…  read on >  read on >

The early months of the COVID-19 pandemic brought a big jump in hospitalizations for life-threatening alcoholic hepatitis at a Detroit health system, new research shows. Alcoholic hepatitis is a liver disease caused by heavy drinking, and these findings add to mounting evidence that many Americans turned to alcohol in an attempt to deal with pandemic…  read on >  read on >

Viagra-like drugs might do more than rejuvenate sex lives: A new study suggests that medications for erectile dysfunction may also help treat vascular dementia. The medications are designed to increase blood flow to the penis in order to treat erectile dysfunction, so U.K. researchers decided to test whether one called tadalafil (Cialis) could also raise…  read on >  read on >

February is American Heart Month — the perfect time to remind women of three things they need to know about heart disease. It’s the leading cause of death among U.S. women, accounting for one in three deaths, according to the American Heart Association (AHA). While progress to reduce that rate has been made in the…  read on >  read on >

The power of COVID booster shots does fade somewhat over four months, but they still continue to provide high levels of protection against severe disease, a new government study has found. Booster effectiveness against hospitalization during the Omicron surge was 91% during the first two months after a third dose, researchers from the U.S. Centers…  read on >  read on >